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Abstract
Background: Contagious Bovine Pleuropneumonia (CBPP), caused by Mycoplasma mycoides subsp. mycoides, is
widespread in sub-Saharan Africa. The current live vaccine T1/44 has limited efficacy and occasionally leads to
severe side effects in the animals. A better understanding of the immune responses triggered by Mycoplasma
mycoides subsp. mycoides and their role in disease progression will help to facilitate the design of a rational
vaccine. Currently, knowledge of cytokines involved in immunity and immunopathology in CBPP is rather limited.
The aim of this study was to characterize the in vivo plasma concentrations of the cytokines TNF-a, IFN-g, IL-4, IL-10
and the overall role of CD4+ T cells in the development of cytokine levels during a primary infection. Plasma
cytokine concentrations in two groups of cattle (CD4+ T cell-depleted and non-depleted cattle) experimentally
infected with Mycoplasma mycoides subsp. mycoides were measured and their relationship to the clinical outcomes
was investigated.
Results: Plasma cytokine concentrations varied between animals in each group. Depletion of CD4+ T cells did not
induce significant changes in plasma levels of TNF-a, IL-4, and IL-10, suggesting a minor role of CD4+ T cells in
regulation or production of the three cytokines during the time window of depletion (1-2 weeks post depletion).
Unexpectedly, the IFN-g concentrations were slightly, but statistically significantly higher in the depleted group (p
< 0.05) between week three and four post infection. Three CD4+ T cell-depleted animals that experienced severe
disease, had high levels of TNF-a and IFN-g. Only one severely diseased non-depleted animal showed a high
serum concentration of IL-4 post infection.
Conclusions: Comparison of most severely diseased animals, which had to be euthanized prior to the expected
date, versus less severe diseased animals, irrespective of the depletion status, suggested that high TNF-a levels are
correlated with more severe pathology in concomitance with high IFN-g levels.
Keywords: Contagious bovine pleuropneumonia, Mycoplasma mycoides subsp. mycoides, Cytokines, TNF-α, IFN-γ, IL-
4, IL-10
Background
Contagious bovine pleuropneumonia (CBPP), caused by
Mycoplasma mycoides subsp. mycoides, is characterized
by a severe fibrinous exudative pleuropneumonia. CBPP
causes decreased productivity and direct losses of cattle,
and on CBPP affected countries rigorous limitation to
international trade are imposed in accordance with
World Organization of Animal Health (OIE) regulation.
The disease has been eradicated in Europe, Asia and
America through the application of restrictions to the
movement of cattle, as well as test and slaughter policies
combined with compensation for livestock keepers. Such
policies are difficult to apply in most African countries
because of pastoralism, lack of economical resources,
and fragmented veterinary services.* Correspondence: jores@web.de2International Livestock Research Institute, Old Naivasha Road, PO Box 30709,
00100 Nairobi, Kenya
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The current live vaccine, based on the attenuated
strain T1/44, confers limited efficacy although it has
been reported to have a degree of pathogenicity [1,2].
Annual revaccinations are necessary to confer a suffi-
cient level of protection for the cattle population. An
improved vaccine conferring long-term immunity is
desirable for control of CBPP in Africa.
A comprehensive understanding of host pathogen
interactions and the identification of protective versus
counter protective immune responses are a prerequisite
for the development of a rational vaccine. Currently,
there is no clear understanding on how to induce solid
immunity against Mycoplasma mycoides subsp. mycoides
or what the main mechanisms of immunity are. Recent
studies have focussed on antibody-mediated immunity
[3,4] and T cell-related immunity [5-7]. However, conclu-
sive results regarding protective or pathological immune
responses could not be obtained. The immune response
to infectious pathogens is mediated by cytokines, thus an
understanding of the kinetics of the different cytokines in
the course of disease is helpful in identifying correlates of
both mild and severe CBPP. Different Mycoplasma
mycoides subsp. mycoides strains activated in vitro bovine
macrophages and induced the release of tumor necrosis
factor alpha (TNF-a) [8]. Likewise heat-killed suspen-
sions of the closely related pathogen Mycoplasma
mycoides subsp. capri activated in vitro murine macro-
phages as well as bone marrow cells and induced cyto-
kines such as TNF-a, ΙL-1, IL-6, and nitric oxide [9].
In this study the plasma levels of three proinflammatory
(TNF-a, IFN-g, IL-4) and one anti-inflammatory cytokine
(IL-10) during a primary infection with Mycoplasma
mycoides subsp. mycoides in ten temporarily CD4+ T cell-
depleted and ten non-depleted animals were measured, in
order to correlate the plasma cytokine levels with disease
outcome and additionally to estimate the role of CD4+
T cells with respect to cytokine production.
Methods
Sample collection
All protocols of this study were designed and performed
in strict accordance with the Kenyan legislation for ani-
mal experimentation and were approved by the institu-
tional animal care and use committee (IACUC reference
number 2008.08). Since 1993, ILRI has complied volunta-
rily with the United Kingdom’s Animals (Scientific Proce-
dures) Act 1986 that contains guidelines and codes of
practice for the housing and care of animals used in
scientific procedures.
The sample population of cattle experimentally
infected with Mycoplasma mycoides subsp. mycoides has
been described previously [5]. Briefly, 20 Kenyan Boran
bullocks (Bos indicus) between 14 and 16 months of age
were intra-tracheally infected using Mycoplasma
mycoides subsp. mycoides Afadé. Ten cattle were
depleted from CD4+ T lymphocytes using a BoCD4 spe-
cific murine monoclonal antibody 6 days post infection
(dpi). Cattle were kept for up to 30 dpi, euthanized and
subjected to post mortem analysis. Blood samples were
obtained before infection and twice a week post infection.
Clinical outcome and pathomorphological lesions of the
sample population have been described in detail before
[5].
Qualitative measurement of IgM, IgG1, IgG2 and IgA
antibody levels
Mycoplasma mycoides subsp. mycoides Afadé was culti-
vated in liquid PPLO media at 37°C for 72 hours and log-
phase culture centrifuged at 14000 × g at 4°C for 40 min.
The cell pellet was washed three times with phosphate
buffered saline (PBS) and resuspended in the same buffer.
Protein concentration was determined using BCA protein
assay kit (Thermo Scientific, Rockford, USA) according
to the manufacturer instructions. Cells were diluted in
bicarbonate buffer (0.05 M, pH 9.6), adjusting antigen
concentration to 10 μg/ml.
ImmunoPolysorp 96-well standard plates (NUNC A/S
Roskilde, Denmark) were coated with 100 μl/well of Myco-
plasma mycoides subsp. mycoides Afadé total antigen as
described above. Microplates were stored at 4°C overnight
and washed with PBST buffer (0.01 M PBS, pH 7.2 with
0.05% Tween 20,). Each well was blocked against unspeci-
fic binding using 200 μl blocking buffer (PBST containing
1% of yeast extract) and microplates were incubated at
37°C for 1 hour and washed afterwards with PBST. Predi-
luted plasma samples (100 μl/well) were added for deter-
mination of IgA, IgG1, IgG2, and IgM responses. Plasma
samples for IgM determination were prediluted 1:2560
while for the other ELISAs a 1:80 predilution was used.
The samples were diluted in PBST with 0.1% of yeast
extract. After incubation at 37°C for 1 hour microplates
were washed using PBST, followed by incubation with sec-
ondary antibodies (100 μl/well) at room temperature for
1 hour. Antibody stock solutions were diluted in PBST
with 0.1% of yeast extract, as outlined: murine anti-bovine
IgG1 HRP conjugated (Abcam, Cambridge, UK), 1:150;
murine anti-bovine IgG2 HRP conjugated (Abcam, Cam-
bridge, UK), 1:150, murine anti-bovine IgA HRP conju-
gated (Bethyl Laboratories, Inc, Montgomery, USA), 1:800;
murine anti-bovine IgM HRP conjugated (Bethyl Labora-
tories, Inc, Montgomery, USA), 1:1000. Afterwards the
plates were washed and 100 μl/well of 3,3’,5,5’-tetra-
methylbenzidine substrate was added, microplates were
incubated at room temperature until optimal colour devel-
opment was observed (5 minutes for IgM ELISA, 20 min-
utes for the other ELISAs) and reaction was stopped using
50 μl of 0.5 N sulphuric acid. Optical density (OD) was
measured using a Benchmark microplate reader (Bio-Rad
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Laboratories) at a wavelength of 450 nm. All measure-
ments have been carried out in duplicate.
In vivo cytokine measurement
Blood samples were collected in Lithium Heparin tubes
before and after experimental infection. Immediately
after collection the samples were centrifuged at 4°C at
2000 × g for 15 min and the plasma was harvested and
stored at -80°C for subsequent analysis. The concentra-
tions of TNF-a, IFN-g, IL-4 and IL-10 were assessed with
the following commercially available ELISA kits: Bovine
TNF-a duo set (R&D System Europe Ltd., UK); Bovine
IFN-g (Mabtech AB, Sweden); Bovine IL-4 Screening Set
(Thermo Scientific, Pierce Biotechnology USA) and
Bovine Interleukin 10 (Cusabio Biotech Co., LTD.). Indi-
vidual tests were performed according to manufacturer’s
instructions. All samples were run in duplicate and
results calculated by interpolation of OD sample values
with the relevant standard curve using SigmaPlot® 11
Systat Software, Inc (San Jose, CA, USA) and expressed
as protein concentration (pg/ml).
Statistical analysis
Absolute cytokine concentrations were natural log trans-
formed (TNF-a and IFN-g) or square rooted (IL-10)
before analysis, to satisfy normality assumptions. A two-
sided two- sample t-test was used to compare the two
groups at each time point. Prior to conducting the t-test
the variances for the two groups were compared using an
F-test. If the variances were significantly unequal then
separate variances were used in the t-test, where the var-
iances were not significantly different a pooled variance
was used. Differences were considered statistically signifi-
cant for p < 0.05.
Results
Sample population
All animals were successfully infected as shown by
mounted antibody titres post infection and the isolation of
the infectious agent from all animals [5]. The depletion of
CD4+ T cells was successful as demonstrated by flow cyto-
metry [5]. Clinical symptoms of CBPP peaked between 12
and 15 dpi. Four animals, three from the depleted group
(BD91, BD98, and BD118) and one from the non-depleted
group (BD97), showed severe clinical symptoms and had
to be euthanized before the planned end of the experiment
for ethical reasons [5]. Cytokine levels of the four animals
were compared with the 16 remaining animals, which had
a milder form of clinical disease. The body temperature of
the four animals was significantly higher than in the other
animals (see Additional file 1: Comparison of body tem-
peratures of cattle showing acute and mild disease symp-
toms). At post mortem examination, typical CBPP lesions
were observed in 19 out of 20 animals [5]. Typology,
extension and lesion severity were variable among the ani-
mals within the groups; no obvious differences, except the
number of animals, which succumbed to disease, between
CD4+ T cell-depleted and non-depleted groups were
observed [5].
Observed cytokine levels during experimental infection in
non-depleted animals
The average TNF-a plasma levels increased slightly after
experimental infection and ranged from 1100 pg/ml to >
1400 pg/ml (see Figure 1A and Additional file 2: TNF-a
plasma concentrations in pg/ml). However, one animal
(BD106) showed a high TNF-a plasma concentration
before infection. In this animal the measured plasma con-
centration of 5400 pg/ml before infection dropped to
2000-3000 pg/ml after experimental infection, despite the
fact that its health status was good at the beginning of the
experiment.
The average IFN-g plasma concentrations increased
post infection from 6.5 pg/ml to > 100 pg/ml and then
remained constant for about two weeks before dropping
three weeks post infection to pre-infection levels (see Fig-
ure 2A and Additional file 3: IFN-g plasma concentra-
tions in pg/ml). The concentration of IFN-g peaked as
high as 1140 pg/ml 9 dpi in animal BD97, which showed
severe clinical and patho-morphological signatures.
IL-4 was only detected in this one severely affected ani-
mal, BD97. The IL-4 concentration increased post infec-
tion from zero up to 340 pg/ml before dropping to 100 pg/
ml before euthanasia. Plasma levels of IL-4 in all other ani-
mals remained below the assay detection limit (see Addi-
tional file 4: IL-4 plasma concentrations in pg/ml).
The average IL-10 plasma levels increased post infection
from 10 pg/ml to 80 pg/ml and stayed high throughout
the experiment (see Figure 3A and Additional file 5: IL-10
plasma concentrations in pg/ml). The highest concentra-
tions were observed in animal BD115, which remained
above 200 pg/ml for most of the time; the peak level was
nearly 300 pg/ml.
Comparison of plasma cytokine levels in CD4+ T cell-
depleted and non-depleted cattle
In order to determine whether CD4+ T cell-depleted cattle
had a different cytokine plasma profile we compared the
two groups (CD4+ T cell-depleted and non-depleted) of
10 cattle each using their cytokine plasma concentrations
and tested for significant differences.
TNF-a
The average TNF-a plasma levels increased in both
groups post infection. The average levels peaked around
1 - 2 weeks post infection and afterwards dropped close
to the initial level in the depleted group while remained
higher than the initial levels in the non- depleted group
Sacchini et al. BMC Veterinary Research 2012, 8:44
http://www.biomedcentral.com/1746-6148/8/44
Page 3 of 8
(Figure 1A). The differences observed were not statisti-
cally significant at the 5% level when compared to the
results of the non-depleted group.
IFN-g
The average IFN-g plasma levels of the CD4+ T cell-
depleted group increased in synchrony with the levels of
the non-depleted group up to three weeks post infec-
tion. The levels dropped afterwards to the values before
infection. The IFN-g plasma levels measured from 20
dpi up to 23 dpi were significantly higher in the CD4+ T
cell-depleted group (p < 0.001 and p = 0.029, respec-
tively) (Figure 2A).
IL-4
None of the CD4+ T cell-depleted animals showed IL-4
levels above the detection limit, while only one non-
depleted animal (BD97) showed an increased level, which
did not allow a statistical comparison of the two groups.
IL-10
The average IL-10 plasma levels of the CD4+ T cell-
depleted group increased after infection as in the non-
depleted group. The average levels peaked around 1-2
weeks post infection and then dropped slightly. The dif-
ferences observed were not statistically significant at the
5% level when compared to the results of the non-
depleted group.
Comparison of plasma cytokine levels in animals with
severe clinical disease and animals with a milder clinical
form of disease
In order to assess the presence and role of cytokines with
respect to the outcome of an infection with Mycoplasma
Figure 1 TNF-a plasma levels during an experimental infection with Mycoplasma mycoides subsp. mycoides Afadé. Comparison of TNF-a
plasma levels in CD4+ T cell-depleted animals (dashed red line) and non-depleted animals (green line) is shown in Figure 1A while the
comparison of plasma levels in severe (black line) and chronic disease (grey line) outcome is displayed in Figure 1B. The day of depletion of CD4
+ T cells is indicated by a red triangle. The standard error bars are displayed. Significant levels are marked (* = p < 0.05).
Figure 2 IFN-g plasma levels during an experimental infection with Mycoplasma mycoides subsp. mycoides Afadé. Comparison of IFN-g
plasma levels in CD4+ T cell- depleted animals (dashed red line) and non-depleted animals (green line) is shown in Figure 2A while the
comparison of plasma levels in severe (black line) and chronic disease (grey line) outcome is displayed in Figure 2B. The day of depletion of CD4+ T
cells is indicated by a red triangle. The standard error bars are displayed. Significant levels are marked (* = p < 0.05, ** = p < 0.01, *** = p < 0.001).
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mycoides subsp. mycoides the animals were grouped
according to their clinical disease severity (severe disease
patterns versus milder disease patterns) and the cytokine
plasma profiles for the two groups were compared. The
four animals BD91, BD97, BD98, and BD118 showed the
most severe course of disease and were euthanized before
the planned end of the experiment. Their pathomorpho-
logical outcome correlated with high disease severity.
Therefore, these four animals were placed into the severe
disease group and statistically compared to the remaining
animals (mild disease).
TNF-a
The average TNF-a plasma levels in the severe disease
group were higher than in the mild disease group
throughout the experiment. The difference was statisti-
cally significant at 9 dpi (p = 0.031) and remained bor-
derline different at 13 dpi (p = 0.057) (Figure 1B). The
levels increased in all animals after infection.
IFN-g
The average IFN-g plasma levels in the severe disease
group was higher than in the mild disease group
throughout the experiment. The difference was signifi-
cant from 2 dpi (p < 0.001) through 16 dpi (p = 0.022)
when the severe disease group of animals began being
removed from the trial (Figure 2B).
IL-4
Only one animal (BD97) in the severe disease group
showed an increased level, which did not allow for sta-
tistical comparisons between the groups.
IL-10
The average IL-10 plasma levels of both the mild and
severe disease groups increased after infection. The
average levels peaked around 1 - 2 weeks post infection
and afterwards dropped slightly. The levels were always
higher in the severe disease group and statistically sig-
nificantly higher (p < 0.05) than the mild disease group
in the first 10 dpi (Figure 3B).
Comparison of plasma immunoglobulin responses in CD4
+ T cell-depleted and non-depleted cattle
In order to determine whether CD4+ T cell-depleted
cattle had a different antibody response we compared
the two groups (CD4+ T cell-depleted and non-depleted)
using ELISA technique and tested for significant
differences.
CD4+ T cell-depleted cattle had a significant higher
IgG1 and IgA titres after depletion at two time points
(see Additional file 6: Observed qualitative Mycoplasma-
specific antibody responses). IgG2 and IgM titres did
not differ significantly between groups.
Comparison of plasma immunoglobulin responses in
animals with severe clinical disease and animals with a
milder clinical form of disease
In order to determine whether animals with severe clini-
cal disease and animals with a milder clinical form of
disease had a different antibody response we compared
the two groups using ELISA technique and tested for
significant differences.
Animals with severe clinical disease had a significant
higher IgG1 (3 time points), IgG2 (2 time points) IgA
and IgM (only 1 time point) (see Additional file 6:
Observed qualitative Mycoplasma-specific antibody
responses).
Discussion
Currently, protective and inflammatory responses during
CBPP are not fully understood. In recent years, IFN-g
Figure 3 IL-10 plasma levels during an experimental infection with Mycoplasma mycoides subsp. mycoides Afadé. Comparison of IL-10
plasma levels in CD4+ T cell-depleted animals (dashed red line) and non-depleted animals (green line) is shown in Figure 3A while the comparison
of plasma levels in severe (black line) and chronic disease (grey line) outcome is displayed in Figure 3B. The day of depletion of CD4+ T cells is
indicated by a red triangle. The standard error bars are displayed. Significant levels are marked (* = p < 0.05).
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and especially IFN-g-secreting CD4+ T cells have been
proposed as key elements required for protection [10], as
their levels were inversely correlated with severity of dis-
ease. A recent study employing murine CD4+ specific
mAb to deplete bovine CD4+ T cells, including the IFN-
g-secreting population, represents the first attempt to
investigate, in vivo, the role of CD4+ T cells in a primary
CBPP infection [5]. Animals were depleted at 6 dpi, since
the time window of complete depletion is less than two
weeks and we wanted to time depletion in the onset of
clinical disease. It cannot be ruled out that CD4+ T cells
contributed to CBPP-specific cytokine responses before
depletion. Four out of twenty animals had to be eutha-
nized before the envisaged end of the trial because of
ethical reasons. This is in the range of reported mortality
of CBPP especially given the fact that those animals were
kept at ideal conditions with food ad libitum and no cli-
mate or production-associated stress. The animals were
monitored for selected in vivo cytokine plasma profiles
during Mycoplasma mycoides subsp. mycoides infection
to see whether the depletion of most CD4+ specific T
cells over a time window had any effects on the cytokine
profiles. Flow cytometry analysis had demonstrated that
the CD4+ T cell depletion was successful and that naïve
CD4+ T cells reappeared approximately ten days post
depletion, but did not reach the levels of control animals
until the end of the experiment [5].
Acute and sub-acute cases of CBPP are characterised
by strong inflammatory reaction leading to serofibrinous
pleuropneumonia, pleural effusion and tissue damage.
We expected a correlation between increased TNF-a
plasma levels and severe clinical signs and/or lesions,
since TNF-a is one of the key inflammatory cytokines
that it is released in large amounts following infection
with gram-negative and other bacteria including myco-
plasmas and is responsible for systemic complications
[11]. An increase of TNF-a in the plasma was observed
in most of the animals following infection, which sup-
ports the hypothesis that TNF-a mediates inflammation
in CBPP. The levels did not increase dramatically, which
might be attributed to the fact that TNF-a is produced
locally, has a short half-life, and so primarily accom-
plishes its effects locally. Therefore, the increase of the
plasma levels might be a signature of what is happening
in certain regions of the lung.
The high degree of lung lobulation and the absence of
collateral airways in the bovine lung often quarantine
inflammatory processes to defined lobes [12] and pre-
vent an inflammation of the entire lung as seen only in
a small fraction of the animals after experimental infec-
tion. The most severely infected animals showed a sig-
nificantly higher level of plasma TNF-a when compared
to the animals showing a milder reaction. However, it
must be noted that only three out of four animals most
severely affected showed very high concentrations of the
cytokine. Conversely, one animal with a mild form of
disease had a very high plasma concentration of TNF-a
throughout the experiment. The data further suggest
that the CD4+ T cell depletion did not have a significant
effect on the TNF-a plasma levels. This is not surpris-
ing, as cells from the macrophage lineage, which are
amply represented by alveolar macrophages, are impor-
tant producers of TNF-a.
Although IFN-g is known to prime macrophages to
secrete more TNF-a after stimulation, the IFN-g in this
experiment frequently peaked later (BD 91, BD 93, BD
95, BD 98, BD 107, BD 118) rather than simultaneously
with TNF-a. This time difference suggests that early
TNF-a secretion is not highly dependent on plasma IFN-
g. Again, local IFN-g release in the lungs, which could
not be detected given the set-up of this experiment,
might have different kinetics and affected TNF-a concen-
trations. It has been shown in vitro that direct exposure
of bovine alveolar macrophages to Mycoplasma mycoides
subsp. mycoides can trigger TNF-a secretion [8]. In vivo
IFN-g measurement showed increased release of the
cytokine in plasma from the depleted group 16 dpi (ten
days post CD4+ T cell depletion). During this period the
percentage of CD4+ cells was less than 1% as demon-
strated by flow cytometric analysis. The CD4+ T cells
that re-appeared derived most likely from the thymus
and were naïve, thus not capable of mounting a prompt
immune response [13]. This implies that CD4+ T cells
are not the main or most important source of IFN-g in
the course of CBPP, and that other cellular compart-
ments must be responsible for IFN-g production. Natural
killer cells, CD8+ T cells or gδ T cells are also capable of
producing IFN-g, but their role in CBPP immune
response has not been elucidated.
Animals that had to be euthanized because of severe
clinical signs had significantly higher levels of plasma
IFN-g in comparison to animals with low pathology
scores. On the other hand, animals with low pathology
scores did not show high IFN-g responses.
This was surprising; since previous studies had shown
that higher IFN-g levels in stimulated cultures of periph-
eral blood mononuclear cells (PBMCs) correlated with
milder disease [10]. Other studies based on similar in
vitro cell culture assays did not confirm the positive cor-
relation between resistance and IFN-g recall responses
from PBMCs [14]. While TNF-a and IFN-g may have a
protective effect or stimulate protective responses, their
concentrations may be linked to the severity of the
infection and the amount of mycoplasma in the host.
Bovine IL-4 is not a Th2 signature cytokine but is asso-
ciated to a Th2 profile [15].
Interestingly, measurable IL-4 plasma concentrations
were only detected in one non-CD 4+ T cell-depleted
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animal (BD97) that developed severe CBPP infection.
This animal also presented high IFN-g levels suggesting
that acute and severe CBPP cases develop an imbal-
anced cytokine release with high level of IFN-g and IL-4
resulting in severe pathology as reported in other cattle
diseases and in some cases of human mycobacterial
infection [16].
Analysis of the anti-inflammatory cytokine IL-10,
which increased in most of the animals between 6 and 13
dpi, showed an interesting correlation between augmen-
ted release of IL-10 and increased plasma levels of TNF-
a or IFN-g. Since most of the animals showing increasing
IL-10 concentrations had pathomorphological signatures
of CBPP, we speculate that the increase in IL-10 is not
sufficient to prevent excessive inflammatory processes
that shape CBPP lung lesions. Future experiments should
include the monitoring of this cytokine in immune ani-
mals. Our findings did not indicate a prominent role for
CD4+ T cells in IL-10 secretion and it is known that
many populations of bovine cells, including Th0, Th1
and Th2 cells, can produce IL-10 [17]. Stimulated human
alveolar macrophages can be induced to produce IL-10
[18], but similar data for cattle are missing.
We characterized IgG1, IgG2, IgA, and IgM antibody
responses against Mycoplasma antigen post infection.
As we did not evaluate the binding affinities of the sec-
ondary reagents we were not able to draw meaningful
conclusions regarding a T1 or T2 bias based upon the
ratio of IgG1 to IgG2 titres [15]. We observed statisti-
cally higher IgG1 and IgG2 responses (see Additional
file 6: Observed qualitative Mycoplasma-specific anti-
body responses) in severely affected animals. Future stu-
dies should evaluate the biological role of these
responses, in particular a possible involvement of
immune complexes in disease progression. Immune
complexes are likely to be formed during CBPP as a
result of high levels of immune globulins in combination
with proinflammatory cytokines. This is the first study
looking for cytokine signatures in cattle that have been
infected with Mycoplasma mycoides subsp. mycoides.
Future studies should focus on whether the cytokine
kinetics observed are the cause of pathoimmunological
reactions or a manifestation of it in order to understand
the disease, design proper control measures and direct
the immune responses of next generation vaccines
properly.
Conclusion
Analysis of selected in vivo cytokine profiles during a
course of CBPP showed a predominant IFN-g-mediated
T1 type of response (IFN-g with no IL-4) in three out of
four animals with most severe clinical course of disease
and pathological lesions. The higher levels of IL-10,
TNF-a and IFN-g in animals showing the most severe
clinical disease strongly suggest their involvement as
either a driver or mediator of immune reactions towards
the pathogen. A lack of CD4+ T cells seems to enhance
the level of plasma IFN-g during the course of disease.
According to our results we speculate that high levels of
IFN-g produced in the early stages of Mycoplasma
mycoides subsp. mycoides infection is disadvantageous to
the host. Additional studies are required to investigate
in parallel the cytokine network that takes place in the
lung following Mycoplasma mycoides subsp. mycoides
infection.
Additional material
Additional file 1: Comparison of body temperatures of cattle
showing acute and mild disease symptoms. Two groups of animals,
which showed acute clinical symptoms (red) and mild clinical symptoms
(blue) are displayed. Significant levels are marked (* = p < 0.05, ** = p <
0.01, *** = p < 0.001).
Additional file 2: TNF-a plasma concentrations in pg/ml.
Additional file 3: IFN-g plasma concentrations in pg/ml.
Additional file 4: IL-4 plasma concentrations in pg/ml.
Additional file 5: IL-10 plasma concentrations in pg/ml.
Additional file 6: Observed qualitative Mycoplasma-specific
antibody responses. The day of depletion of CD4+ T cells is indicated
by a red triangle.
Abbreviations
CBPP: Contagious bovine pleuropneumonia; dpi: Days post infection; ELISA:
Enzyme-linked Immunosorbent Assay; IFN-γ: Interferon gamma; IgA:
Immunoglobulin A; IgG: Immunoglobulin G; IgM: Immunoglobulin M; IL-4:
Interleukin 4; IL-10: Interleukin 10; OD: Optical density; TNF-α: Tumor necrosis
factor alpha.
Acknowledgements
This study was funded by grant IZSAM 06/06 RC from the Italian Ministry of
Health. The work was supported by a GTZ grant (contract 81099876, project
No 05.7860.9- 001.00). The German Federal Ministry for Economic
Cooperation and Development supported Joerg Jores. We thank Gisella
Armillotta and Chiara Di Pancrazio for their technical help as well as Anne
Liljander for her critical review of the manuscript. This is ILRI publication
number IL-201104.
Author details
1Istituto “G. Caporale”, via Campo Boario, 64100 Teramo, Italy. 2International
Livestock Research Institute, Old Naivasha Road, PO Box 30709, 00100
Nairobi, Kenya.
Authors’ contributions
FS and JJ designed the study. FS and JJ drafted the manuscript. FS and ML
did the ELISA work. JP and RS did the statistical analysis. All authors
interpreted the data and revised critically the manuscript. FS and JJ
coordinated the whole study. All authors read and approved the final
manuscript.
Received: 29 November 2011 Accepted: 25 April 2012
Published: 25 April 2012
References
1. Thiaucourt F, Yaya A, Wesonga H, Huebschle OJ, Tulasne JJ, Provost A:
Contagious bovine pleuropneumonia. A reassessment of the efficacy of
vaccines used in Africa. Ann N Y Acad Sci 2000, 916:71-80.
Sacchini et al. BMC Veterinary Research 2012, 8:44
http://www.biomedcentral.com/1746-6148/8/44
Page 7 of 8
2. Mbulu RS, Tjipura-Zaire G, Lelli R, Frey J, Pilo P, Vilei EM, Mettler F,
Nicholas RA, Huebschle OJ: Contagious bovine pleuropneumonia (CBPP)
caused by vaccine strain T1/44 of Mycoplasma mycoides subsp. mycoides
SC. Vet Microbiol 2004, 98(3-4):229-234.
3. Niang M, Diallo M, Cisse O, Kone M, Doucoure M, Roth JA, Balcer-
Rodrigues V, Dedieu L: Pulmonary and serum antibody responses elicited
in zebu cattle experimentally infected with Mycoplasma mycoides subsp.
mycoides SC by contact exposure. Vet Res 2006, 37(5):733-744.
4. Hamsten C, Tjipura-Zaire G, McAuliffe L, Huebschle OJ, Scacchia M,
Ayling RD, Persson A: Protein-specific analysis of humoral immune
responses in a clinical trial for vaccines against contagious bovine
pleuropneumonia. Clin Vaccine Immunol 2010, 17(5):853-861.
5. Sacchini F, Naessens J, Awino E, Heller M, Hlinak A, Haider W, Sterner-
Kock A, Jores J: A minor role of CD4+ T lymphocytes in the control of a
primary infection of cattle with Mycoplasma mycoides subsp. mycoides.
Vet Res 2011, 42(1):77.
6. Totte P, Duperray C, Dedieu L: CD62L defines a subset of pathogen-
specific bovine CD4 with central memory cell characteristics. Dev Comp
Immunol 2010, 34(2):177-182.
7. Totte P, Rodrigues V, Yaya A, Hamadou B, Cisse O, Diallo M, Niang M,
Thiaucourt F, Dedieu L: Analysis of cellular responses to Mycoplasma
mycoides subsp. mycoides small colony biotype associated with control
of contagious bovine pleuropneumonia. Vet Res 2008, 39(1):8.
8. Jungi TW, Krampe M, Sileghem M, Griot C, Nicolet J: Differential and
strain-specific triggering of bovine alveolar macrophage effector
functions by mycoplasmas. Microb Pathog 1996, 21(6):487-498.
9. Rosendal S, Levisohn S, Gallily R: Cytokines induced in vitro by
Mycoplasma mycoides ssp. mycoides, large colony type. Vet Immunol
Immunopathol 1995, 44(3-4):269-278.
10. Dedieu L, Balcer-Rodrigues V, Yaya A, Hamadou B, Cisse O, Diallo M,
Niang M: Gamma interferon-producing CD4 T-cells correlate with
resistance to Mycoplasma mycoides subsp. mycoides S.C. infection in
cattle. Vet Immunol Immunopathol 2005, 107(3-4):217-233.
11. Murphy KP, Travers P, Walport M: Janeway’s immunobiology. New York:
Garland Science;, 7 2007.
12. Kirschvink N, Reinhold P: Use of alternative animals as asthma models.
Curr Drug Targets 2008, 9(6):470-484.
13. Naessens J, Scheerlinck JP, De Buysscher EV, Kennedy D, Sileghem M:
Effective in vivo depletion of T cell subpopulations and loss of memory
cells in cattle using mouse monoclonal antibodies. Vet Immunol
Immunopathol 1998, 64(3):219-234.
14. Jores J, Nkando I, Sterner-Kock A, Haider W, Poole J, Unger H, Muriuki C,
Wesonga H, Taracha EL: Assessment of in vitro interferon-gamma
responses from peripheral blood mononuclear cells of cattle infected
with Mycoplasma mycoides ssp. mycoides small colony type. Vet Immunol
Immunopathol 2008, 124(1-2):192-197.
15. Estes DM, Brown WC: Type 1 and type 2 responses in regulation of Ig
isotype expression in cattle. Vet Immunol Immunopathol 2002, 90(1-
2):1-10.
16. Rhodes SG, Graham SP: Is ‘timing’ important for cytokine polarization?
Trends Immunol 2002, 23(5):246-249.
17. Brown WC, Rice-Ficht AC, Estes DM: Bovine type 1 and type 2 responses.
Vet Immunol Immunopathol 1998, 63(1-2):45-55.
18. Chanteux H, Guisset AC, Pilette C, Sibille Y: LPS induces IL-10 production
by human alveolar macrophages via MAPKinases- and Sp1-dependent
mechanisms. Respir Res 2007, 8:71.
doi:10.1186/1746-6148-8-44
Cite this article as: Sacchini et al.: Plasma levels of TNF-a, IFN-g, IL-4 and
IL-10 during a course of experimental contagious bovine
pleuropneumonia. BMC Veterinary Research 2012 8:44.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sacchini et al. BMC Veterinary Research 2012, 8:44
http://www.biomedcentral.com/1746-6148/8/44
Page 8 of 8
